Immunologic Impact of Dupilumab in Patients Suffering From Asthma and Chronic Rhinosinusitis With Polyps
Clinical trial NCT06556264 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06556264
- Sponsor
- Dr. Andrew Thamboo, MD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2025-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.